Regucalcin is an androgen-target gene in the rat prostate modulating cell-cycle and apoptotic pathways

Regucalcin (RGN) is a calcium (Ca(2+) )-binding protein underexpressed in prostate adenocarcinoma comparatively to non-neoplastic prostate or benign prostate hyperplasia cases. Moreover, RGN expression is negatively associated with the cellular differentiation of prostate adenocarcinoma, suggesting...

Full description

Bibliographic Details
Main Author: Vaz, C V (author)
Other Authors: Baptista, Cláudio (author), Marques, Ricardo (author), Gomes, Inês M (author), Correia, Sara (author), Alves, Marco G (author), Cavaco, JE (author), Oliveira, Pedro F (author), Socorro, Sílvia (author)
Format: article
Language:eng
Published: 2019
Subjects:
Androgen
Apoptosis
Proliferation
Prostate
Regucalcin
Online Access:http://hdl.handle.net/10400.6/7649
Country:Portugal
Oai:oai:ubibliorum.ubi.pt:10400.6/7649

Internet

http://hdl.handle.net/10400.6/7649

Similar Items